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At baseline, results showed a prevalence of persons reporting having forgone care because of costs of 15.7% (95% CI 12.5%-18.9%), with dental (9.7%) and foot (5.2%) care most often reported to have been forgone (other types of care forgone being each reported by b 2% of the participants). Table 1 summarizes characteristics of all 519 baseline participants, globally and according to their forgoing care status. People having forgone care were more likely to be women, non-Swiss, to receive health insurance subsidies, in poorer subjective health, report more co-morbidities, and be inactive; they also visited as many healthcare professionals and as often as the people not forgoing care, were more likely to have been hospitalized or have had emergency/ non-scheduled visits during the past twelve months, yet more likely to have participated in education classes.
Primary and secondary baseline processes and outcomes of care results, according to the forgoing care status (Table 1) show that there were no statistically significant differences between the two groups, except for (health-related) quality of life which appeared significantly worse for persons forgoing care. Longitudinal analyses did not show a significant impact on the evolution of the quality of care patients with diabetes forgoing care, after three years (data not shown).
The prevalence of forgoing care among patients with diabetes was similar to that of the general Swiss population, situated at around 15% in 2013 for respondents declaring one or more chronic condition [1] . Moreover, the socio-demographics, household income and subjective health of this study's participants reporting forgoing care because of costs were similar to previous studies not targeting specifically persons with diabetes [6] . Whereas participants who declared forgoing care at baseline, reported suggestive evidence of high healthcare utilization and worse (health-related) quality of life, compared to participants not forgoing care, the three-year evolution over time did not seem to impact the medium-term quality of care of these persons, even when considering potential confounding variables. The somewhat paradoxical reports of forgoing care because of costs yet over-utilization of other types of care (emergency visits) could be explained by the reimbursement of certain care and not of others (i.e. dental and podiatric care) with the overall compensatory effect that the three-year quality of care had not worsened or that the power of the study was not enough to detect an effect.
This study showed that forgoing care because of costs concerned approximately one out of six persons living with diabetes. Although it did not show an impact on the quality of care of those patients in a threeyear period, this should not lead to an underestimation of the potential risk to the health of people forgoing care. Healthcare practitioners should be aware of that issue and investigate what types of care are forgone and how to minimize them. Further examination of how health and care of people with chronic conditions, who declare forgoing care, evolves in the long run, should be carried out. It should also assess what the corresponding patient-reported unmet need is and whether it is recognized by the practitioner. People forgoing care because of costs are less well off than those not forgoing care and need stronger support to maintain stable overall health and quality of care. Healthcare systems, in Switzerland and elsewhere, should therefore strive to 
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